Shanghai Hile Bio-Technology Co., Ltd.

SHSE:603718 Stock Report

Market Cap: CN¥4.6b

Shanghai Hile Bio-Technology Management

Management criteria checks 2/4

Shanghai Hile Bio-Technology's CEO is Benyi Han, appointed in Aug 2023, has a tenure of 2.25 years. directly owns 0.42% of the company’s shares, worth CN¥19.03M. The average tenure of the management team and the board of directors is 1.9 years and 3.5 years respectively.

Key information

Benyi Han

Chief executive officer

CN¥1.1m

Total compensation

CEO salary percentagen/a
CEO tenure2.3yrs
CEO ownership0.4%
Management average tenure1.9yrs
Board average tenure3.5yrs

Recent management updates

Recent updates

Health Check: How Prudently Does Shanghai Hile Bio-Technology (SHSE:603718) Use Debt?

Dec 17
Health Check: How Prudently Does Shanghai Hile Bio-Technology (SHSE:603718) Use Debt?

Shanghai Hile Bio-Technology Co., Ltd.'s (SHSE:603718) 28% Share Price Surge Not Quite Adding Up

Nov 14
Shanghai Hile Bio-Technology Co., Ltd.'s (SHSE:603718) 28% Share Price Surge Not Quite Adding Up

Investor Optimism Abounds Shanghai Hile Bio-Technology Co., Ltd. (SHSE:603718) But Growth Is Lacking

Sep 30
Investor Optimism Abounds Shanghai Hile Bio-Technology Co., Ltd. (SHSE:603718) But Growth Is Lacking

There May Be Some Bright Spots In Shanghai Hile Bio-Technology's (SHSE:603718) Earnings

May 06
There May Be Some Bright Spots In Shanghai Hile Bio-Technology's (SHSE:603718) Earnings

Earnings Not Telling The Story For Shanghai Hile Bio-Technology Co., Ltd. (SHSE:603718)

Apr 29
Earnings Not Telling The Story For Shanghai Hile Bio-Technology Co., Ltd. (SHSE:603718)

CEO

Benyi Han (60 yo)

2.3yrs
Tenure
CN¥1,089,867
Compensation

Mr. Benyi Han is GM & Director of Shanghai Hile Bio-Technology Co., Ltd. from August 17, 2023.


Leadership Team

NamePositionTenureCompensationOwnership
Benyi Han
GM & Director2.3yrsCN¥1.09m0.42%
CN¥ 19.0m
Wang Xingchun
Financial Officer1.5yrsCN¥414.13kno data
Xiao Chen
Deputy GM & Directorno dataCN¥1.12mno data
Dongchan Pu
Deputy GM & Secretary of the Board9.1yrsCN¥511.75k0.069%
CN¥ 3.2m
Xiang Xiaoqiang
Deputy General Manager1.1yrsCN¥298.66kno data
1.9yrs
Average Tenure
46yo
Average Age

Experienced Management: 603718's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Benyi Han
GM & Director2.3yrsCN¥1.09m0.42%
CN¥ 19.0m
Xiao Chen
Deputy GM & Directorno dataCN¥1.12mno data
Hai Ming Zhang
Chairman3.5yrsCN¥421.20k1.9%
CN¥ 87.0m
Qun Lin
Director4.5yrsCN¥261.50k0.069%
CN¥ 3.2m
Hua Ji
Chairman of the Supervisory Board4.5yrsno datano data
Junqiang Wang
Independent Director3.5yrsCN¥60.00kno data
Yusheng Zhou
Supervisor2.3yrsno datano data
Cao Jun
Independent Director1yrCN¥5.00kno data
Zhang Linchao
Independent Directorno dataCN¥35.00kno data
3.5yrs
Average Tenure
57yo
Average Age

Experienced Board: 603718's board of directors are considered experienced (3.5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/19 10:14
End of Day Share Price 2025/11/19 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Shanghai Hile Bio-Technology Co., Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jiao ChenIndustrial Securities Co. Ltd.
Yanhai GongSWS Research Co., Ltd.
Li WuTianfeng Securities Brokerage Co., Ltd